Healthcare
Advent buys Indian biopharma player
Advent International has agreed to acquire a controlling position in Bharat Serums and Vaccines, an Indian biopharmaceuticals supplier focused on the women’s health segment.
Unison agrees $526m Japan pharma carve-out
Unison Capital has agreed to buy Kyowa Pharmaceutical Industry, a Japanese subsidiary of India-headquartered drug manufacturer Lupin for an enterprise valuation of JPY57.4 billion ($526 million).
Deal focus: BGH taps LP expertise for Australia, NZ dentistry deal
Ontario Teachers' Pension Plan is the sole LP co-investor in BGH Capital's acquisition of Abano Healthcare by virtue of its previous experience with dentistry chain assets
Chinese medical device start-up receives $100m
Chinese medical instrument provider Peijia Medical has raised a RMB700 million ($100 million) Series C round from a group including Matrix Partners China and Lilly Asia Ventures.
CICC, AstraZeneca launch $1b China healthcare fund
China International Capital Corporation (CICC) and global pharmaceutical giant AstraZeneca are looking to raise $1 billion for a fund that will back Chinese healthcare companies as well as international players looking to enter the country.
Chinese antibody drug developer raises $150m
Akeso Biopharma, a Chinese biotech company specializing in antibody drugs, has raised a $150 million Series D round led by Loyal Valley Capital and Sino Biopharm.
China's I-Mab Biopharma pursues US IPO
I-Mab Biopharma, the product of a CBC Group-engineered merger of two Chinese drug developers, has announced plans for a NASDAQ IPO.
Biotech player Ascentage gains on debut after $53m HK IPO
Ascentage Pharma saw its share price surge 57% during the first day of trading in Hong Kong before closing up 9.9%, following a heavily oversubscribed HK$416.6 million ($53 million) IPO.
Goldman leads $62m Series D for China's Fountain Medical
Fountain Medical Development, a China-based contract research organization (CRO) that serves a global client base of drug developers, has received $62 million in Series D funding led by Goldman Sachs.
ARQ Capital backs Philippines dialysis business
ARQ Capital, a Philippines-based GP focused on the local small to medium-sized enterprise (SME) sector, has invested an undisclosed sum in dialysis clinic operator Medline.
Merck launches China seed fund
Germany-based life sciences and healthcare technology giant Merck has launched a RMB100 million ($14.1 million) seed fund targeting Chinese start-ups.
Chinese healthcare software provider raises $212m
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs) has raised RMB1.5 billion ($212 million) through an extended Series E round of funding.
Chinese investors lead round for US influenza specialist
Ansun BioPharma, a US-based drug developer led by a former executive at healthcare-focused VC firms Caduceus Asia Partners and OrbiMed, has raised $80 million in Series B funding from a predominantly Chinese investor base.
Indonesia’s Alodokter gets $33m Series C
Indonesian insurer Sequis Life has led a $33 million Series C round of funding for Alodokter, a local super app operator that connects patients with doctors and healthcare information.
Chinese cosmetic surgery business seeks $32.5m in US IPO
Aesthetic Medical International Holdings, a Chinese cosmetic surgery chain that failed to get traction with a Hong Kong IPO four years ago, has filed to list in the US. Its private equity backers include IDG Capital and ADV Partners.
Chinese medical SaaS platform raises $14m Series B
Mingyi Zhonghe, a software-as-a-service (SaaS) platform serving China’s rural clinics, has secured a RMB100 million ($14 million) Series B round led by Sinovation Ventures. Existing investor Yijing Capital re-upped.
GGV backs Singapore dental 3D printing company
GGV Capital has joined a group of investors in a venture round of undisclosed size for Structo, a Singapore-based 3D printing company focused on the dental industry.
KKR, GIC to invest $680m in Philippines hospital operator
A KKR-led consortium has agreed to invest PHP35.3 billion ($680 million) in Metro Pacific Hospital Holdings (MPHH), prompting the Philippines-based hospital operator to abandon immediate plans for an IPO.
Globis, WiL, Japan Post back Series B for AI Medical
AI Medical Service, a Japanese healthcare technology start-up working on what it claims is the world’s first artificial intelligence-enabled endoscopic diagnosis system, has raised JPY4.6 billion ($43 million) in Series B funding.
Co-Stone leads $28m Series B for Chinese gene sequencer
Gene+ Technology, a Chinese provider of gene sequencing services used to support cancer diagnoses, has raised RMB200 million ($28 million) in a Series B round led by Co-Stone Asset Management.
New Mountain Capital buys US-India BPO player
US private equity firm New Mountain Capital has agreed to acquire Emids, a US-headquartered business process outsourcing (BPO) provider with extensive operations in India, for an undisclosed sum.
New Zealand’s Fonterra exits pharma business to CVC
New Zealand dairy group Fonterra has agreed to sell its stake in DFE Pharma, a 50-50 joint venture with Royal FrieslandCampina of the Netherlands, to CVC Capital Partners for NZ$633 million ($398 million).
PE consortium makes $4.6b take-private bid for China Biologic
Centurium Capital, CITIC Capital and Hillhouse Capital are part of an investor group targeting a $4.6 billion take-private of China Biologic – just over a year after committing new equity to the US-listed company to protect it from other would-be acquirers.
China healthcare AI: A learning process
Most healthcare-focused artificial intelligence start-ups in China focus on image-based diagnosis assistance, but deep learning-based drug discovery might be the key application
